Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone-impregnated Spacers in Chronic Rhinosinusitis
NCT01420471Phase 4Completed
- Sponsor
- St. Paul's Hospital
- Start
- Sep 2011
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of triamcinolone in chronic rhinosinusitis (CRS) (2 arms), sponsored by St. Paul's Hospital. Primary endpoints: Post-operative endoscopic appearance at 6 months and Post-operative inflammation at 3 months. Started Sep 2011; status: completed.
02
Drugs
triamcinolone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01420471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01420471.